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The genetic information in eukaryotic cells is organized in
a specific structure called chromatin. The basic unit of
chromatin is the nucleosome, which consist of four histone
proteins and ~147 bp of DNA [1]. The N-terminal tails of
these proteins contain sited for post-translational modifica-
tions directly linked to gene expression. The modifications
include acetylation, methylation, phosphorylation, ubiquiti-
nylation, sumoylation and ribosylation. Specific enzymes
mediate each modification. LSD1 (Lysine Specific
Demethylase I) is one of the histone demethylases, which
removes one methyl group from mono- or di-methylated
lysine residue. It has recently been demonstrated that
androgen receptor (AR)-LSD1 complex demethylates a
repressive histone mark (H3K9) promoting genes activa-
tion [2]. Experimental data show, also, that LSD1 is
strongly expressed in prostate cancers [3]. For these
reasons, specific modulation of LSD1 might be a promising
therapeutic strategy in tissues where AR has a key physio-
logical role. LSD1 is a flavin-dependent amine oxidase,
which shares sequence identity with other flavin dependent
amine oxidases like monoamine oxidase (MAO), and
polyamine oxidase (PAO). After we analyzed structural dif-
ferences and similarities among these enzymes several
docking studies were evaluated using the available crystal
structures of LSD1 and the related oxidases to discover
novel LSD1 inhibitors. For the evaluation studies we
selected different ligand data sets containing known inhibi-
tors of MAO and PAO. The docking setup that showed the
highest accuracy and enrichment factors was selected for
virtual screening of LSD1 inhibitors. Preliminary biological
data were obtained and will be discussed in the context of
the target structure.
Author details
1Institut für Pharmazeutische Chemie, Martin-Luther-Universität Halle-
Wittenberg, Halle/Saale 06120, Germany. 2Institut für Pharmazeutische
Wissenschaften, Albert-Ludwigs-Universität Freiburg, Freiburg, 79104,
Germany.
Published: 22 March 2013
References
1. Luger K, Mäder AW, Richmond RK, Sargent TF, Richmond TJ: Crystal
structure of the nucleosome core particle at 2.8 A resolution. Nature
1997, 389:251-260.
2. Metzger E, Wissmann M, Yin N, Müller JM, Schneider R, Peters AHFM,
Günther T, Buettner R, Schüle R: LSD1 demethylates repressive histone
marks to promote androgen-receptor-dependent transcription. Nature
2005, 437:436-439.
3. Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R,
Solleder G, Bastian PJ, Ellinger J, Metzger E, Schüle R, Buettner R: Androgen
receptor coactivators lysine-specific histone demethylase 1 and four and
a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Recurr Cancer Res 2006, 66:11341-11347.
doi:10.1186/1758-2946-5-S1-P41
Cite this article as: Carlino et al.: Ligand-based and structure-based
design of novel histone demethylase inhibitors. Journal of
Cheminformatics 2013 5(Suppl 1):P41.
Open access provides opportunities to our 
colleagues in other parts of the globe, by allowing 
anyone to view the content free of charge.
Publish with ChemistryCentral and every
scientist can read your work free of charge
W. Jeffery Hurst, The Hershey Company.
available free of charge to the entire scientific community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours     you keep the copyright
Submit your manuscript here:
http://www.chemistrycentral.com/manuscript/
* Correspondence: carlino.luca@gmail.com
1Institut für Pharmazeutische Chemie, Martin-Luther-Universität Halle-
Wittenberg, Halle/Saale 06120, Germany
Full list of author information is available at the end of the article
Carlino et al. Journal of Cheminformatics 2013, 5(Suppl 1):P41
http://www.jcheminf.com/content/5/S1/P41
© 2013 Carlino et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
